I am humbled and honored to serve as the Director of Preventive Cardiology @ISHVnews. Looking forward to working with my amazing colleagues in improving CVH for all. Thanks to @coconnormd and Inova leadership for their support!

Beyond thrilled for this publication highlighting the importance of nutrition with patient education in reducing #cvd https://t.co/E9KyCNF4H1 @cardio10s @PanjrathG Monica Aggarwal @rinaagustinaja Keith Ferdinand @NicoleLohrMD

Congratulations to the incoming class of cardiology fellows! We are excited to welcome you to Inova and work with you. @ISHVnews @JamieLWKennedy @vbluml @RezaEmaminia

Enjoy the best experience on X.

We have an opening for a 1-2 year fellowship in @ishv Women's CVH and Preventive Cardiology starting July 2026. Please email Lina.Escobar@inova.org with CV, 2 LORs and Statement of interest. We will interview and finalize in Jan 2026. @JSpitz_MD @DrDastmalchi @BrazileTiffany

Guiding Obstetric Care and Treatment Decisions for Women With Prior GLP-1 Receptor Agonist Use

Increasing Postpartum Use of GLP-1 Receptor Agonists Most users were overweight prior to pregnancy and only 23% had a documented diabetes diagnosis, suggesting that the primary indication for use was weight reduction. https://t.co/lpPpAI9ooa

1/3 🎉 Thrilled to share my presentations from #AHA2025! GLP-1 Receptor Agonists Use in Pregnant Women Reduce Adverse Maternal and Fetal Outcomes: A Meta-Analysis 🤰30% lower adverse maternal outcomes & reduced preterm births in GLP-1 RA group Read more: https://t.co/Se7eycnozC

BOOM 💥

Don't miss this amazing opportunity to showcase your work to Leaders in Women’s CVH! Garima Sharma, MD; Nandita Scott, MD Noel Bairey Merz, MD #CardioObstetrics #WomensCVH #YIA competition. Abstracts due 1/9/26; Email Elizabeth.Wilson@Inova.org for more information

Celebrating Dwight & Martha Schar & our endowed Chairs. @coconnormd Schar Distinguished Chair, ISHV, @_WayneBatchelor Schar Chair, ISHV; Steven Nathan, Schar Chair, Adv Lung/TXP Program; Richard Neville, Schar Chair, Vasc Surgery; @GarimaVSharmaMD Martha Schar Chair, Women’s CVH

Incredibly honored to officially receive the Martha Schar Endowed Chair in Women’s CVH @ISHVnews . 🙏 my mentors , mentees and collaborators in this journey. Its wonderful to have institutional support and commitment towards advancing care for women @coconnormd @ShashankDesai08

In the lesson "Hypertension in Midlife Women," learn about blood pressure changes during menopause, modern diagnostic tools, and home-based strategies for timely identification and management. Learn more with #ACCEd: https://t.co/GAunI8qLL5 @GarimaVSharmaMD

If you order my new book The Final Score TODAY I promise that I will fight ALL of these men in the next video. You have never seen a 72 year old kick this much butt in one video. Amazon and Barnes Noble selling for $21.00

Cannot not share this 😅

No clear evidence to support any link between maternal acetaminophen (Tylenol) intake and autism or ADHD in offspring, a new umbrella systematic review @bmj_latest

Congratulations to @drstaceyrosen, President of the American Heart Association, on a powerful and inspiring Presidential Address. Even more special — the incredible Northwell Choir performing in her honor. #AHA2025 @KatzWomensHlth @avolgman @GarimaVSharmaMD @SharonneHayes

Great discussion on #SCAD and #MINOCA with these amazing colleagues @AHAScience #AHA2025 @katherinekleon

So incredibly proud of this team. Thank you coaches and teammates for a great senior season. Went 9-3 and 6-0 in district. First district championship in a decade and first playoff win in 4 years. @coachfanning93 @CadeBell_AHS @CoachGood_2 @J_ChristensenQB @CoachTyeFrancis

What an amazing time @ISHVnews Happy Hour! Thanks to all our faculty, trainees, post-docs and collaborators! @AHAScience #AHA2025 @ycommodore @fmetlock @JSpitz_MD @AnaBaracCardio @DrDastmalchi @InovaCVfellows @BrazileTiffany

@AHAScience in full speed #AHA25 If you are not at the posters you are missing the future of Prevention, Imaging and AI in #CardioOnc. Congratulations to All Presenters! So proud of @BrazileTiffany leading implementation of Echo-AI. @InovaCVfellows

We announced positive late-breaking Phase 1 data for CTX310 at #AHA25, demonstrating deep and durable ANGPTL3 editing with lowering of triglyceride and lipid levels, published in @NEJM. A major milestone for our in vivo gene-editing platform. https://t.co/gNfsO9kBW8

ANGPTL3 results presented at #AHA25

Can it really be a coincidence? Smart Investors Hold Gold. Find out more at Goldhub

#LateBreakers- DR10624 Novel triple therapeutic - FGF21R, GCGR, GLP-1R- significant TG lowering and impressive liver fat reduction (~50% normalized) #AHA2025 @ChiadiNdumele @EugeniaGianos @CBallantyneMD @PamelaBMorris

Incredible packed opening to #AHA2025 @drstaceyrosen #Madamepresident leads with brilliance @JoChikweMD program chair inspires with real world patient experience @DrOz @CMSGov reminds us of @AHAScience mission to improve the lives of all focusing on science & advocacy